Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Merck And Co Inc News

Merck Braces for Keytruda Patent Expiration — Here's Its Strategy - Stocktwits

04 Feb, 2026

Merck exceeds quarterly projections and provides conservative guidance for 2026 amid impending generic competition.

03 Feb, 2026

Merck exceeds Q4 profit forecasts but provides a less optimistic outlook for 2026 - TradingView

03 Feb, 2026

Merck projects 2026 revenue to fall short of expectations due to patent expirations - The Globe and Mail

03 Feb, 2026

See More